English

VIA Pharmaceuticals, Inc.

EDGAR

Annual report (10-K) · filed 2011-03-24

66 filing records in this dataset, filed from 1996-05-15 to 2011-03-24. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2010-12-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source
Revenue: 0 USD Source

Operating cash flow

-1.19 million USD

2010-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -6106270 USD Source
Operating Cash Flow: -4912347 USD Source

Free cash flow

-1.19 million USD

2010-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -6106270 USD Source
Operating Cash Flow: -4912347 USD Source
Capital Expenditure: 0 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 84 thousand USD 2010-12-31 Source
Exact value

84001 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2010-01-01 – 2010-12-31

Exact inputs and evidence

Revenue: 0 USD · 2010-01-01 – 2010-03-31 Source
Revenue: 0 USD · 2010-04-01 – 2010-06-30 Source
Revenue: 0 USD · 2010-07-01 – 2010-09-30 Source
Revenue: 0 USD · 2010-01-01 – 2010-12-31 Source
Revenue: 0 USD · 2010-01-01 – 2010-09-30 Source

Net income

-9.6 million USD

2010-01-01 – 2010-12-31

Exact inputs and evidence

Net income: -2919753 USD · 2010-01-01 – 2010-03-31 Source
Net income: -2092638 USD · 2010-04-01 – 2010-06-30 Source
Net income: -2118323 USD · 2010-07-01 – 2010-09-30 Source
Net income: -9601315 USD · 2010-01-01 – 2010-12-31 Source
Net income: -7130714 USD · 2010-01-01 – 2010-09-30 Source

Operating cash flow

-6.11 million USD

2010-01-01 – 2010-12-31

Exact inputs and evidence

Operating cash flow: -2941603 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -3881924 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: -2941603 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -4912347 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: -3881924 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: -6106270 USD · 2010-01-01 – 2010-12-31 Source
Operating cash flow: -4912347 USD · 2010-01-01 – 2010-09-30 Source

Capital expenditure

0 USD

2010-01-01 – 2010-12-31

Exact inputs and evidence

Capital expenditure: 0 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 0 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 0 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 0 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 0 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 0 USD · 2010-01-01 – 2010-12-31 Source
Capital expenditure: 0 USD · 2010-01-01 – 2010-09-30 Source

Free cash flow

-6.11 million USD

2010-01-01 – 2010-12-31

Exact inputs and evidence

Operating cash flow: -2941603 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -3881924 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: -2941603 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -4912347 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: -3881924 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: -6106270 USD · 2010-01-01 – 2010-12-31 Source
Operating cash flow: -4912347 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 0 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 0 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 0 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 0 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 0 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 0 USD · 2010-01-01 – 2010-12-31 Source
Capital expenditure: 0 USD · 2010-01-01 – 2010-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-03-24.

Financial data available through: 2010-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2010-12-31
Operating income: 11 of 11 periods available· newest 2010-12-31
Net income: 11 of 11 periods available· newest 2010-12-31
Operating cash flow: 11 of 11 periods available· newest 2010-12-31
Capital expenditure: 11 of 11 periods available· newest 2010-12-31
Total assets: 5 of 11 periods available· newest 2006-12-31
Total liabilities: 7 of 11 periods available· newest 2010-12-31
Current assets: 11 of 11 periods available· newest 2010-12-31
Current liabilities: 11 of 11 periods available· newest 2010-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2010-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2009-01-01 – 2009-12-31
Current period

USD 0

2010-01-01 – 2010-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
0 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · VIA Pharmaceuticals, Inc. · 2010-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#15499 Input fundies:Revenue: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#15499
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 11.38 million

Prior period

−USD 20.98 million

2009-01-01 – 2009-12-31
Current period

−USD 9.6 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

-9601315 − -20978324 = 11377009 USD

-20978324 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
-9601315 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · VIA Pharmaceuticals, Inc. · 2010-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Year-over-year change in Net income: 11377009 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -9601315 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20210 Input fundies:NetIncome: -20978324 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20210
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 5.75 million

Prior period

−USD 11.86 million

2009-01-01 – 2009-12-31
Current period

−USD 6.11 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

-6106270 − -11861112 = 5754842 USD

-11861112 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
-6106270 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · VIA Pharmaceuticals, Inc. · 2010-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Year-over-year change in Operating cash flow: 5754842 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -6106270 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20417 Input fundies:OperatingCashFlow: -11861112 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20417
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 16,155

2009-01-01 – 2009-12-31
Current period

USD 0

2010-01-01 – 2010-12-31

Exact inputs and evidence

0 − 16155 = -16155 USD

16155 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
0 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · VIA Pharmaceuticals, Inc. · 2010-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Year-over-year change in Capital expenditure: -16155 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20459 Input fundies:CapitalExpenditure: 16155 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20459
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2010-01-01 – 2010-12-31

Revenue USD 0
Operating costs Derived USD 6.02 million
Operating income −USD 6.02 million
Tax, interest and other Derived USD 3.58 million
Net income −USD 9.6 million

Cash

Operating cash flow −USD 6.11 million
Capital expenditure USD 0
Free cash flow Derived −USD 6.11 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2001 Operating loss: operating costs were 4,046% of revenue.
2002 Operating loss: operating costs were 1,194% of revenue.
2003 Operating loss: operating costs were 87,543% of revenue.
2004 Operating loss: operating costs were 12,330% of revenue.
2005 Operating loss: operating costs were 23,815% of revenue.
2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.
2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.
2010 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2001 2001-01-01 – 2001-12-31	300900	12174589 Derived	-11873689	-778679 Derived	-11095010	-11601272 Derived	Source 2001-01-01 – 2001-12-31: 300900 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -11873689 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -11095010 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -10881736 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 719536 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	1120438	13373111 Derived	-12252673	-199090 Derived	-12053583	-10826661 Derived	Source 2002-01-01 – 2002-12-31: 1120438 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -12252673 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -12053583 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -9224850 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 1601811 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	34722	30396711 Derived	-30361989	46157 Derived	-30408146	-7664109 Derived	Source 2003-01-01 – 2003-12-31: 34722 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -30361989 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -30408146 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -7567506 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 96603 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	83333	10274568 Derived	-10191235	190738 Derived	-10381973	-10172385 Derived	Source 2004-01-01 – 2004-12-31: 83333 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -10191235 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -10381973 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -10147665 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 24720 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	83333	19846129 Derived	-19762796	-25953 Derived	-19736843	-18180779 Derived	Source 2005-01-01 – 2005-12-31: 83333 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -19762796 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -19736843 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -18132632 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 48147 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	0	8223418 Derived	-8223418	403469 Derived	-8626887	-8304435 Derived	Source 2006-01-01 – 2006-12-31: 0 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -8223418 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -8626887 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -8157903 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 146532 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	0	22348988 Derived	-22348988	-513606 Derived	-21835382	-19209874 Derived	Source 2007-01-01 – 2007-12-31: 0 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -22348988 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -21835382 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -18938768 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 271106 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	0	20461219 Derived	-20461219	-186391 Derived	-20274828	-19034448 Derived	Source 2008-01-01 – 2008-12-31: 0 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -20461219 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -20274828 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -18893795 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 140653 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	0	13253535 Derived	-13253535	7724789 Derived	-20978324	-11877267 Derived	Source 2009-01-01 – 2009-12-31: 0 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -13253535 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -20978324 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -11861112 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 16155 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	0	6020941 Derived	-6020941	3580374 Derived	-9601315	-6106270 Derived	Source 2010-01-01 – 2010-12-31: 0 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -6020941 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -9601315 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -6106270 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Revenue	300900	Revenue: 300900 Open source
20022002-12-31	Revenue	1120438	Revenue: 1120438 Open source
20032003-12-31	Revenue	34722	Revenue: 34722 Open source
20042004-12-31	Revenue	83333	Revenue: 83333 Open source
20052005-12-31	Revenue	83333	Revenue: 83333 Open source
20062006-12-31	Revenue	0	Revenue: 0 Open source
20072007-12-31	Revenue	0	Revenue: 0 Open source
20082008-12-31	Revenue	0	Revenue: 0 Open source
20092009-12-31	Revenue	0	Revenue: 0 Open source
20102010-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2006

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Year over year	86%	Revenue: 300900 Open source Revenue: 161763 Open source
20022002-12-31	Year over year	272.4%	Revenue: 1120438 Open source Revenue: 300900 Open source
20032003-12-31	Year over year	-96.9%	Revenue: 34722 Open source Revenue: 1120438 Open source
20042004-12-31	Year over year	140%	Revenue: 83333 Open source Revenue: 34722 Open source
20052005-12-31	Year over year	0%	Revenue: 83333 Open source Revenue: 83333 Open source
20062006-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 83333 Open source
20072007-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20082008-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20092009-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20102010-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -23,715.5% 2005

Net margin -23,684.3% 2005

Free cash flow margin -21,817% 2005

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Operating margin	-3,946.1%	Operating Income: -11873689 Open source Revenue: 300900 Open source
20022002-12-31	Operating margin	-1,093.6%	Operating Income: -12252673 Open source Revenue: 1120438 Open source
20032003-12-31	Operating margin	-87,443.1%	Operating Income: -30361989 Open source Revenue: 34722 Open source
20042004-12-31	Operating margin	-12,229.5%	Operating Income: -10191235 Open source Revenue: 83333 Open source
20052005-12-31	Operating margin	-23,715.5%	Operating Income: -19762796 Open source Revenue: 83333 Open source
20062006-12-31	Operating margin	Not reported	Operating Income: -8223418 Open source Revenue: 0 Open source
20072007-12-31	Operating margin	Not reported	Operating Income: -22348988 Open source Revenue: 0 Open source
20082008-12-31	Operating margin	Not reported	Operating Income: -20461219 Open source Revenue: 0 Open source
20092009-12-31	Operating margin	Not reported	Operating Income: -13253535 Open source Revenue: 0 Open source
20102010-12-31	Operating margin	Not reported	Operating Income: -6020941 Open source Revenue: 0 Open source
20012001-12-31	Net margin	-3,687.3%	Net Income: -11095010 Open source Revenue: 300900 Open source
20022002-12-31	Net margin	-1,075.8%	Net Income: -12053583 Open source Revenue: 1120438 Open source
20032003-12-31	Net margin	-87,576%	Net Income: -30408146 Open source Revenue: 34722 Open source
20042004-12-31	Net margin	-12,458.4%	Net Income: -10381973 Open source Revenue: 83333 Open source
20052005-12-31	Net margin	-23,684.3%	Net Income: -19736843 Open source Revenue: 83333 Open source
20062006-12-31	Net margin	Not reported	Net Income: -8626887 Open source Revenue: 0 Open source
20072007-12-31	Net margin	Not reported	Net Income: -21835382 Open source Revenue: 0 Open source
20082008-12-31	Net margin	Not reported	Net Income: -20274828 Open source Revenue: 0 Open source
20092009-12-31	Net margin	Not reported	Net Income: -20978324 Open source Revenue: 0 Open source
20102010-12-31	Net margin	Not reported	Net Income: -9601315 Open source Revenue: 0 Open source
20012001-12-31	Free cash flow margin	-3,855.5%	Revenue: 300900 Open source Operating Cash Flow: -10881736 Open source Capital Expenditure: 719536 Open source
20022002-12-31	Free cash flow margin	-966.3%	Revenue: 1120438 Open source Operating Cash Flow: -9224850 Open source Capital Expenditure: 1601811 Open source
20032003-12-31	Free cash flow margin	-22,072.8%	Revenue: 34722 Open source Operating Cash Flow: -7567506 Open source Capital Expenditure: 96603 Open source
20042004-12-31	Free cash flow margin	-12,206.9%	Revenue: 83333 Open source Operating Cash Flow: -10147665 Open source Capital Expenditure: 24720 Open source
20052005-12-31	Free cash flow margin	-21,817%	Revenue: 83333 Open source Operating Cash Flow: -18132632 Open source Capital Expenditure: 48147 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -8157903 Open source Capital Expenditure: 146532 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -18938768 Open source Capital Expenditure: 271106 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -18893795 Open source Capital Expenditure: 140653 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -11861112 Open source Capital Expenditure: 16155 Open source
20102010-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -6106270 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -6.1M 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Operating cash flow	-10881736	Operating Cash Flow: -10881736 Open source
20022002-12-31	Operating cash flow	-9224850	Operating Cash Flow: -9224850 Open source
20032003-12-31	Operating cash flow	-7567506	Operating Cash Flow: -7567506 Open source
20042004-12-31	Operating cash flow	-10147665	Operating Cash Flow: -10147665 Open source
20052005-12-31	Operating cash flow	-18132632	Operating Cash Flow: -18132632 Open source
20062006-12-31	Operating cash flow	-8157903	Operating Cash Flow: -8157903 Open source
20072007-12-31	Operating cash flow	-18938768	Operating Cash Flow: -18938768 Open source
20082008-12-31	Operating cash flow	-18893795	Operating Cash Flow: -18893795 Open source
20092009-12-31	Operating cash flow	-11861112	Operating Cash Flow: -11861112 Open source
20102010-12-31	Operating cash flow	-6106270	Operating Cash Flow: -6106270 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -6.1M 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Free cash flow	-11601272	Operating Cash Flow: -10881736 Open source Capital Expenditure: 719536 Open source
20022002-12-31	Free cash flow	-10826661	Operating Cash Flow: -9224850 Open source Capital Expenditure: 1601811 Open source
20032003-12-31	Free cash flow	-7664109	Operating Cash Flow: -7567506 Open source Capital Expenditure: 96603 Open source
20042004-12-31	Free cash flow	-10172385	Operating Cash Flow: -10147665 Open source Capital Expenditure: 24720 Open source
20052005-12-31	Free cash flow	-18180779	Operating Cash Flow: -18132632 Open source Capital Expenditure: 48147 Open source
20062006-12-31	Free cash flow	-8304435	Operating Cash Flow: -8157903 Open source Capital Expenditure: 146532 Open source
20072007-12-31	Free cash flow	-19209874	Operating Cash Flow: -18938768 Open source Capital Expenditure: 271106 Open source
20082008-12-31	Free cash flow	-19034448	Operating Cash Flow: -18893795 Open source Capital Expenditure: 140653 Open source
20092009-12-31	Free cash flow	-11877267	Operating Cash Flow: -11861112 Open source Capital Expenditure: 16155 Open source
20102010-12-31	Free cash flow	-6106270	Operating Cash Flow: -6106270 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

58.5% 2006

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2001-12-31	Liabilities / assets	Not reported	No source recorded
2002-12-31	Liabilities / assets	Not reported	No source recorded
2003-12-31	Liabilities / assets	Not reported	Total Assets: 10534035 Open source
20042004-12-31	Liabilities / assets	56.8%	Total Liabilities: 14782736 Open source Total Assets: 26014656 Open source
20052005-12-31	Liabilities / assets	66.5%	Total Liabilities: 20949181 Open source Total Assets: 31511413 Open source
20062006-12-31	Liabilities / assets	58.5%	Total Liabilities: 9600325 Open source Total Assets: 16417073 Open source
20072007-12-31	Liabilities / assets	Not reported	Total Liabilities: 3933203 Open source
20082008-12-31	Liabilities / assets	Not reported	Total Liabilities: 3436919 Open source
20092009-12-31	Liabilities / assets	Not reported	Total Liabilities: 13754724 Open source
20102010-12-31	Liabilities / assets	Not reported	Total Liabilities: 18997473 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.02× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Current assets / current liabilities	9.58×	Current Assets: 17171148 Open source Current Liabilities: 1791657 Open source
20022002-12-31	Current assets / current liabilities	1.63×	Current Assets: 5331691 Open source Current Liabilities: 3271084 Open source
20032003-12-31	Current assets / current liabilities	3.37×	Current Assets: 9596144 Open source Current Liabilities: 2845602 Open source
20042004-12-31	Current assets / current liabilities	9.78×	Current Assets: 25202218 Open source Current Liabilities: 2575738 Open source
20052005-12-31	Current assets / current liabilities	7.63×	Current Assets: 31405110 Open source Current Liabilities: 4113843 Open source
20062006-12-31	Current assets / current liabilities	0.36×	Current Assets: 3448467 Open source Current Liabilities: 9593498 Open source
20072007-12-31	Current assets / current liabilities	6.12×	Current Assets: 24052111 Open source Current Liabilities: 3929223 Open source
20082008-12-31	Current assets / current liabilities	1.37×	Current Assets: 4668625 Open source Current Liabilities: 3406282 Open source
20092009-12-31	Current assets / current liabilities	0.17×	Current Assets: 2345103 Open source Current Liabilities: 13717274 Open source
20102010-12-31	Current assets / current liabilities	0.02×	Current Assets: 444325 Open source Current Liabilities: 18989073 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2001-01-01 – 2001-12-31	−USD 11.1 million Exact value Exact value: -11095010 USD 2001-01-01 – 2001-12-31: -11095010 USD Inspect Net Income Open source Share or cite Citation for Net Income · VIA Pharmaceuticals, Inc. · 2001-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Net Income: -11095010 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11095010 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-04-053878.txt#9599 The citation records this snapshot. The page link may show a newer release later.	−USD 10.88 million Exact value Exact value: -10881736 USD 2001-01-01 – 2001-12-31: -10881736 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIA Pharmaceuticals, Inc. · 2001-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Operating Cash Flow: -10881736 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10881736 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-04-053878.txt#9978 The citation records this snapshot. The page link may show a newer release later.	USD 719,536 Exact value Exact value: 719536 USD 2001-01-01 – 2001-12-31: 719536 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIA Pharmaceuticals, Inc. · 2001-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Capital Expenditure: 719536 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 719536 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-04-053878.txt#10068 The citation records this snapshot. The page link may show a newer release later.	−USD 11.6 million Calculation and evidence -10881736 − 719536 USD Exact free cash flow: -11601272 USD 2001-01-01 – 2001-12-31: -10881736 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 719536 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIA Pharmaceuticals, Inc. · 2001-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Free cash flow: -11601272 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10881736 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-04-053878.txt#9978 Input fundies:CapitalExpenditure: 719536 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-04-053878.txt#10068 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 12.05 million Exact value Exact value: -12053583 USD 2002-01-01 – 2002-12-31: -12053583 USD Inspect Net Income Open source Share or cite Citation for Net Income · VIA Pharmaceuticals, Inc. · 2002-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Net Income: -12053583 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12053583 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-05-057596.txt#9981 The citation records this snapshot. The page link may show a newer release later.	−USD 9.22 million Exact value Exact value: -9224850 USD 2002-01-01 – 2002-12-31: -9224850 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIA Pharmaceuticals, Inc. · 2002-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Operating Cash Flow: -9224850 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9224850 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-05-057596.txt#10396 The citation records this snapshot. The page link may show a newer release later.	USD 1.6 million Exact value Exact value: 1601811 USD 2002-01-01 – 2002-12-31: 1601811 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIA Pharmaceuticals, Inc. · 2002-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Capital Expenditure: 1601811 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1601811 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-05-057596.txt#10486 The citation records this snapshot. The page link may show a newer release later.	−USD 10.83 million Calculation and evidence -9224850 − 1601811 USD Exact free cash flow: -10826661 USD 2002-01-01 – 2002-12-31: -9224850 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 1601811 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIA Pharmaceuticals, Inc. · 2002-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Free cash flow: -10826661 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9224850 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-05-057596.txt#10396 Input fundies:CapitalExpenditure: 1601811 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-05-057596.txt#10486 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 30.41 million Exact value Exact value: -30408146 USD 2003-01-01 – 2003-12-31: -30408146 USD Inspect Net Income Open source Share or cite Citation for Net Income · VIA Pharmaceuticals, Inc. · 2003-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Net Income: -30408146 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -30408146 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-06-059156.txt#10023 The citation records this snapshot. The page link may show a newer release later.	−USD 7.57 million Exact value Exact value: -7567506 USD 2003-01-01 – 2003-12-31: -7567506 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIA Pharmaceuticals, Inc. · 2003-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Operating Cash Flow: -7567506 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7567506 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-06-059156.txt#10402 The citation records this snapshot. The page link may show a newer release later.	USD 96,603 Exact value Exact value: 96603 USD 2003-01-01 – 2003-12-31: 96603 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIA Pharmaceuticals, Inc. · 2003-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Capital Expenditure: 96603 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 96603 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-06-059156.txt#10492 The citation records this snapshot. The page link may show a newer release later.	−USD 7.66 million Calculation and evidence -7567506 − 96603 USD Exact free cash flow: -7664109 USD 2003-01-01 – 2003-12-31: -7567506 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 96603 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIA Pharmaceuticals, Inc. · 2003-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Free cash flow: -7664109 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7567506 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-06-059156.txt#10402 Input fundies:CapitalExpenditure: 96603 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-06-059156.txt#10492 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 10.38 million Exact value Exact value: -10381973 USD 2004-01-01 – 2004-12-31: -10381973 USD Inspect Net Income Open source Share or cite Citation for Net Income · VIA Pharmaceuticals, Inc. · 2004-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Net Income: -10381973 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10381973 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-07-070762.txt#10084 The citation records this snapshot. The page link may show a newer release later.	−USD 10.15 million Exact value Exact value: -10147665 USD 2004-01-01 – 2004-12-31: -10147665 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIA Pharmaceuticals, Inc. · 2004-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Operating Cash Flow: -10147665 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10147665 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-07-070762.txt#10463 The citation records this snapshot. The page link may show a newer release later.	USD 24,720 Exact value Exact value: 24720 USD 2004-01-01 – 2004-12-31: 24720 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIA Pharmaceuticals, Inc. · 2004-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Capital Expenditure: 24720 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 24720 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-07-070762.txt#10559 The citation records this snapshot. The page link may show a newer release later.	−USD 10.17 million Calculation and evidence -10147665 − 24720 USD Exact free cash flow: -10172385 USD 2004-01-01 – 2004-12-31: -10147665 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 24720 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIA Pharmaceuticals, Inc. · 2004-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Free cash flow: -10172385 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10147665 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-07-070762.txt#10463 Input fundies:CapitalExpenditure: 24720 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-07-070762.txt#10559 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 19.74 million Exact value Exact value: -19736843 USD 2005-01-01 – 2005-12-31: -19736843 USD Inspect Net Income Open source Share or cite Citation for Net Income · VIA Pharmaceuticals, Inc. · 2005-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Net Income: -19736843 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19736843 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-07-070762.txt#10084 The citation records this snapshot. The page link may show a newer release later.	−USD 18.13 million Exact value Exact value: -18132632 USD 2005-01-01 – 2005-12-31: -18132632 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIA Pharmaceuticals, Inc. · 2005-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Operating Cash Flow: -18132632 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18132632 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-07-070762.txt#10463 The citation records this snapshot. The page link may show a newer release later.	USD 48,147 Exact value Exact value: 48147 USD 2005-01-01 – 2005-12-31: 48147 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIA Pharmaceuticals, Inc. · 2005-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Capital Expenditure: 48147 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 48147 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-07-070762.txt#10559 The citation records this snapshot. The page link may show a newer release later.	−USD 18.18 million Calculation and evidence -18132632 − 48147 USD Exact free cash flow: -18180779 USD 2005-01-01 – 2005-12-31: -18132632 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 48147 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIA Pharmaceuticals, Inc. · 2005-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Free cash flow: -18180779 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18132632 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-07-070762.txt#10463 Input fundies:CapitalExpenditure: 48147 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0001193125-07-070762.txt#10559 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 8.63 million Exact value Exact value: -8626887 USD 2006-01-01 – 2006-12-31: -8626887 USD Inspect Net Income Open source Share or cite Citation for Net Income · VIA Pharmaceuticals, Inc. · 2006-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Net Income: -8626887 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8626887 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950134-08-005596.txt#26921 The citation records this snapshot. The page link may show a newer release later.	−USD 8.16 million Exact value Exact value: -8157903 USD 2006-01-01 – 2006-12-31: -8157903 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIA Pharmaceuticals, Inc. · 2006-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Operating Cash Flow: -8157903 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8157903 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950134-08-005596.txt#27436 The citation records this snapshot. The page link may show a newer release later.	USD 146,532 Exact value Exact value: 146532 USD 2006-01-01 – 2006-12-31: 146532 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIA Pharmaceuticals, Inc. · 2006-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Capital Expenditure: 146532 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 146532 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950134-08-005596.txt#27563 The citation records this snapshot. The page link may show a newer release later.	−USD 8.3 million Calculation and evidence -8157903 − 146532 USD Exact free cash flow: -8304435 USD 2006-01-01 – 2006-12-31: -8157903 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 146532 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIA Pharmaceuticals, Inc. · 2006-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Free cash flow: -8304435 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8157903 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950134-08-005596.txt#27436 Input fundies:CapitalExpenditure: 146532 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950134-08-005596.txt#27563 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 21.84 million Exact value Exact value: -21835382 USD 2007-01-01 – 2007-12-31: -21835382 USD Inspect Net Income Open source Share or cite Citation for Net Income · VIA Pharmaceuticals, Inc. · 2007-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Net Income: -21835382 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21835382 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950134-09-006232.txt#28347 The citation records this snapshot. The page link may show a newer release later.	−USD 18.94 million Exact value Exact value: -18938768 USD 2007-01-01 – 2007-12-31: -18938768 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIA Pharmaceuticals, Inc. · 2007-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Operating Cash Flow: -18938768 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18938768 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950134-09-006232.txt#28905 The citation records this snapshot. The page link may show a newer release later.	USD 271,106 Exact value Exact value: 271106 USD 2007-01-01 – 2007-12-31: 271106 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIA Pharmaceuticals, Inc. · 2007-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Capital Expenditure: 271106 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 271106 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950134-09-006232.txt#29032 The citation records this snapshot. The page link may show a newer release later.	−USD 19.21 million Calculation and evidence -18938768 − 271106 USD Exact free cash flow: -19209874 USD 2007-01-01 – 2007-12-31: -18938768 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 271106 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIA Pharmaceuticals, Inc. · 2007-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Free cash flow: -19209874 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18938768 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950134-09-006232.txt#28905 Input fundies:CapitalExpenditure: 271106 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950134-09-006232.txt#29032 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 20.27 million Exact value Exact value: -20274828 USD 2008-01-01 – 2008-12-31: -20274828 USD Inspect Net Income Open source Share or cite Citation for Net Income · VIA Pharmaceuticals, Inc. · 2008-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Net Income: -20274828 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20274828 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-10-030615.txt#14485 The citation records this snapshot. The page link may show a newer release later.	−USD 18.89 million Exact value Exact value: -18893795 USD 2008-01-01 – 2008-12-31: -18893795 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIA Pharmaceuticals, Inc. · 2008-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Operating Cash Flow: -18893795 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18893795 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-10-030615.txt#14692 The citation records this snapshot. The page link may show a newer release later.	USD 140,653 Exact value Exact value: 140653 USD 2008-01-01 – 2008-12-31: 140653 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIA Pharmaceuticals, Inc. · 2008-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Capital Expenditure: 140653 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 140653 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-10-030615.txt#14734 The citation records this snapshot. The page link may show a newer release later.	−USD 19.03 million Calculation and evidence -18893795 − 140653 USD Exact free cash flow: -19034448 USD 2008-01-01 – 2008-12-31: -18893795 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 140653 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIA Pharmaceuticals, Inc. · 2008-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Free cash flow: -19034448 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18893795 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-10-030615.txt#14692 Input fundies:CapitalExpenditure: 140653 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-10-030615.txt#14734 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 20.98 million Exact value Exact value: -20978324 USD 2009-01-01 – 2009-12-31: -20978324 USD Inspect Net Income Open source Share or cite Citation for Net Income · VIA Pharmaceuticals, Inc. · 2009-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Net Income: -20978324 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20978324 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20210 The citation records this snapshot. The page link may show a newer release later.	−USD 11.86 million Exact value Exact value: -11861112 USD 2009-01-01 – 2009-12-31: -11861112 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIA Pharmaceuticals, Inc. · 2009-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Operating Cash Flow: -11861112 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11861112 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20417 The citation records this snapshot. The page link may show a newer release later.	USD 16,155 Exact value Exact value: 16155 USD 2009-01-01 – 2009-12-31: 16155 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIA Pharmaceuticals, Inc. · 2009-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Capital Expenditure: 16155 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16155 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20459 The citation records this snapshot. The page link may show a newer release later.	−USD 11.88 million Calculation and evidence -11861112 − 16155 USD Exact free cash flow: -11877267 USD 2009-01-01 – 2009-12-31: -11861112 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 16155 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIA Pharmaceuticals, Inc. · 2009-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Free cash flow: -11877267 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11861112 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20417 Input fundies:CapitalExpenditure: 16155 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20459 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 9.6 million Exact value Exact value: -9601315 USD 2010-01-01 – 2010-12-31: -9601315 USD Inspect Net Income Open source Share or cite Citation for Net Income · VIA Pharmaceuticals, Inc. · 2010-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Net Income: -9601315 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9601315 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20210 The citation records this snapshot. The page link may show a newer release later.	−USD 6.11 million Exact value Exact value: -6106270 USD 2010-01-01 – 2010-12-31: -6106270 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIA Pharmaceuticals, Inc. · 2010-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Operating Cash Flow: -6106270 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6106270 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20417 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2010-01-01 – 2010-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIA Pharmaceuticals, Inc. · 2010-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20459 The citation records this snapshot. The page link may show a newer release later.	−USD 6.11 million Calculation and evidence -6106270 − 0 USD Exact free cash flow: -6106270 USD 2010-01-01 – 2010-12-31: -6106270 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIA Pharmaceuticals, Inc. · 2010-12-31 VIA Pharmaceuticals, Inc. (edgar:1003929) Free cash flow: -6106270 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:49:40Z Snapshot: 189ad3d5613e62b7cd0128227801be04f436c1a9f0fc54719df6ae4f8991770b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003929?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6106270 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20417 Input fundies:CapitalExpenditure: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003929/0000950123-11-028637.txt#20459 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

66 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001003929, 1003929, edgar:1003929

Also known as CORAUTUS GENETICS INC, GENSTAR THERAPEUTICS CORP, UROGEN CORP

VIA Pharmaceuticals, Inc.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2010 2010-01-01 – 2010-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation